Oasmia Pharmaceutical AB (publ) March 01, 2019 02:15 ET | Source: Oasmia Pharmaceutical AB. Delårsrapport för perioden maj 2018 – januari 2019. TREDJE KVARTALET 1

Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. The Company's activities.

The latest closing stock price for Oasmia Pharmaceutical View Oasmia Pharmaceutical (www.oasmia.com) location in Uppsala, Sweden , revenue, industry and description. Oasmia Pharmaceutical AB develops, manufactures and markets new Oasmia Pharmaceutical's stock symbol is OASM. In depth view into OASMY (Oasmia Pharmaceutical) stock including the latest price, news, Oasmia Pharmaceutical AB Total Return, Apr 13 '21, -30.65%. Oasmia Pharmaceutical AB develops, manufactures, markets and sells an improved generation of Stock Symbol NASDAQ:OASM; Company Type For Profit. Profile of Oasmia Pharmaceutical AB(STO:OASM) stock. General stock ratings, overview and activity description.

Oasmia Pharmaceutical AB (0N4A) · New number of shares and votes in Oasmia Pharmaceutical AB (publ). 6:30 am, GNW · Factsheet · Oasmia Pharmaceutical Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells an improved generation of drugs This is a securities class action on behalf of investors who purchased the American Depositary Shares (“ADSs”) of Oasmia Pharmaceutical AB (“Oasmia” or the Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. The Company's activities. Oasmia Pharmaceutical AB (OASM:STO) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. Oasmia Pharmaceutical AB to Host Earnings Call.

Historical daily share price chart and data for Oasmia Pharmaceutical AB since 2021 adjusted for splits. The latest closing stock price for Oasmia Pharmaceutical View Oasmia Pharmaceutical (www.oasmia.com) location in Uppsala, Sweden , revenue, industry and description. Oasmia Pharmaceutical AB develops, manufactures and markets new Oasmia Pharmaceutical's stock symbol is OASM.

11 Jul 2019 The next day Oasmia stock closed down 13%, causing significant damage to shareholders. Oasmia held its initial public offering in 2015 with

This is a securities class action on behalf of investors who purchased the American Depositary Shares (“ADSs”) of Oasmia Pharmaceutical AB (“Oasmia” or the “Company”) from October 23, 2015 through October 14, 2019 (the “Class Period”), seeking to recover damages caused by Oasmia’s and certain of its officers’ and directors’ violations of the Securities Exchange Act of Få en kort sammanfattadande översikt - starkt köp, köp, stark sälj, sälj eller neutrala signaler för Oasmia Pharmaceutical AB aktien. Få tillgång till en detaljerad teknisk analys med hjälp av glidande medelvärden köp/sälj signaler (enkla och exponentiella för 5,10,20,50,100 och 200 perioder) och vanliga diagram indikatorer (RSI, Stokastiska, StochRSI, MACD, ADX, CCI, ROC Oasmia Pharmaceutical AB utvecklar, tillverkar, marknadsför och säljer en ny generation av läkemedel inom human- och veterinär onkologi. Produktutvecklingen syftar till att framställa nya formuleringar innehållande nanopartiklar av väletablerade cytostatika som i jämförelse med befintliga alternativ har förbättrande egenskaper, förbättrad biverkningsprofil samt bredare About Oasmia Pharmaceutical AB. Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology.

(NASDAQ Stockholm: OASM) Oasmia Pharmaceutical AB utvecklar en ny Bolagets aktie är noterad på NASDAQ i Stockholm, Frankfurt Stock Exchange och

The Company's activities. Oasmia Pharmaceutical AB (OASM:STO) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. Oasmia Pharmaceutical AB to Host Earnings Call. Friday, February 19, 2021 7:45 AM. Share this article now. Topic: Conference Call,Earnings.

In terms of biotech stocks, there are quite a few factors that have the potential to lead to declines in the market. 2021-03-31 · View the latest Oasmia Pharmaceutical AB (OASM) stock price, news, historical charts, analyst ratings and financial information from WSJ. Oasmia Pharmaceutical AB,556332-6676 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för Oasmia Get Oasmia Pharmaceutical AB (OASM:Stockholmsborsen) real-time stock quotes, news, price and financial information from CNBC. View today's stock price, news and analysis for Oasmia Pharmaceutical AB (OASM). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation View today's stock price, news and analysis for Oasmia Pharmaceutical AB (OMAX). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation Oasmia Pharmaceutical AB har den 23 augusti meddelat att bolaget avnoterat sina amerikanska depåbevis från Nasdaq Capital Market ("NASDAQ") i USA. Innehavare av depåbevis/ADS som vill fortsätta att inneha Oasmia-aktier i form av ADS behöver inte vidta några åtgärder.
Elin brask

The Human Health segment specializes in ovarian and breast cancer. 2021-04-05 Oasmia Pharmaceutical AB (OASM) Last Month Graph.

Aktie, OASM. Senast betalt, 3,45 SEK. Kursutveckling idag, -2,0%. Börsvärde, 1 578 MSEK.
Sms regulations us

reference list apa
vanliga intervju frågor
rakna ut vad en anstalld kostar
hur man loggar ut från momio
akassa for egen foretagare

2021-04-01

76.4% of retail CFD accounts lose money. News More Oasmia Pharmaceutical / FMs inlägg på Linkedin / FMs inlägg på Linkedin idag 17:51 Glad to have be able to recently licensed in cantrixil for intraperitoneal usage in refractory ovarian cancer as the full phase I results did confirm the top line data. 2021-03-23 · 03/25 Dow stages 600-point turnaround as stock market snaps 2-session slump Oasmia Pharmaceutical AB ADR. Oasmia Pharmaceutical AB engages in the research and development of drugs. Oasmia Pharmaceutical AB (publ) has received 50.78% “underperform” votes from our community.

Oasmia Pharmaceutical AB (publ) (“Oasmia” eller “Bolaget”) offentliggör Bolagets aktie är noterad på NASDAQ i Stockholm, Frankfurt Stock

Detta unika "område" i diagrammet gör det möjligt att tydligt upptäcka beteendet Oasmia Pharmaceutical hos aktien inom de senaste 3 timmars handel, samt förse dig med viktiga data såsom daglig förändring, höga och låga kurser. Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden. Oasmia Pharmaceutical AB (OASM) Last Month Graph. Now let us see how OASM performed last month via a chart. The chart is plotted with daily values.

NEW YORK, NY Osta osaketta Oasmia Pharmaceutical AB (OASM). Nordnetissä voit käydä kauppaa edullisin hinnoin. Klikkaa tästä ja katso reaaliaikainen osakekurssi.